P
P. Mark Bloomston
Researcher at Ohio State University
Publications - 4
Citations - 2447
P. Mark Bloomston is an academic researcher from Ohio State University. The author has contributed to research in topics: Cancer & Biliary tract. The author has an hindex of 4, co-authored 4 publications receiving 2352 citations. Previous affiliations of P. Mark Bloomston include Northwestern University.
Papers
More filters
Journal ArticleDOI
NCCN clinical practice guidelines in oncology: hepatobiliary cancers.
Al B. Benson,Thomas A. Abrams,Edgar Ben-Josef,P. Mark Bloomston,Jean F. Botha,Bryan M. Clary,Anne M. Covey,Steven A. Curley,Michael I. D'Angelica,Rene Davila,William D. Ensminger,John F. Gibbs,Daniel Laheru,Mokenge P. Malafa,Jorge Marrero,Steven G. Meranze,Sean J. Mulvihill,James O. Park,James A. Posey,Jasgit Sachdev,Riad Salem,Elin R. Sigurdson,Constantinos T. Sofocleous,Jean-Nicolas Vauthey,Alan P. Venook,Laura W. Goff,Yun Yen,Andrew X. Zhu +27 more
Journal ArticleDOI
Hepatobiliary cancers, version 2.2014.
Al B. Benson,Michael I. D’Angelica,Thomas A. Abrams,Chandrakanth Are,P. Mark Bloomston,Daniel T. Chang,Bryan M. Clary,Anne M. Covey,William D. Ensminger,Renuka Iyer,R. Kate Kelley,David C. Linehan,Mokenge P. Malafa,Steven G. Meranze,James O. Park,Timothy M. Pawlik,James Posey,Courtney L. Scaife,Tracey E. Schefter,Elin R. Sigurdson,G. Gary Tian,Jean Nicolas Vauthey,Alan P. Venook,Yun Yen,Andrew X. Zhu,Karin G. Hoffmann,Nicole R. McMillian,Hema Sundar +27 more
TL;DR: This manuscript focuses on the clinical management of patients with gallbladder cancer and cholangiocarcinomas (intrahepatic and extrahePatic).
Journal ArticleDOI
Laparoscopic Distal Pancreatectomy with Splenic Conservation: An Operation without Increased Morbidity
Peter Nau,W. Scott Melvin,Vimal K. Narula,P. Mark Bloomston,E. Christopher Ellison,Peter Muscarella +5 more
TL;DR: The laparoscopic distal pancreatectomy is a safe operation with a low morbidity and Splenic conservation does not significantly increase the morbidity of the procedure.
Journal ArticleDOI
Circulating interleukin-6 is associated with disease progression, but not cachexia in pancreatic cancer.
Mitchell L. Ramsey,Erin E. Talbert,Daniel H. Ahn,Tanios Bekaii-Saab,Niharika Badi,P. Mark Bloomston,Darwin L. Conwell,Zobeida Cruz-Monserrate,Mary Dillhoff,Matthew R. Farren,Alice Hinton,Somashekar G. Krishna,Gregory B. Lesinski,Thomas A. Mace,Andrei Manilchuk,Anne M. Noonan,Timothy M. Pawlik,Priyani V. Rajasekera,Carl Schmidt,Denis C. Guttridge,Phil A. Hart +20 more
TL;DR: Circulating IL-6 levels do not correlate with cachexia (when defined by weight loss), but rather with advanced cancer stage, which suggests that IL- 6 may mediate wasting, but should not be considered a diagnostic biomarker for PDAC-induced cachexia.